{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:17:36Z","timestamp":1791566256222,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijid.2024.107020","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:10:53Z","timestamp":1711473053000},"page":"107020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical evaluation of antifungal de-escalation in Candida infections: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-670X","authenticated-orcid":false,"given":"Marta","family":"Albanell-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-4371","authenticated-orcid":false,"given":"Fernando","family":"Salazar Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalla","family":"Montero P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4119-0834","authenticated-orcid":false,"given":"Victoria","family":"Aniyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4459-6059","authenticated-orcid":false,"given":"Francisco-Javier","family":"Carrera Hueso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-0811","authenticated-orcid":false,"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Garc\u00eda-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Puerta-Alcalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"V\u00e1zquez Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijid.2024.107020_bib0001","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ijcp.12231","article-title":"Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience","volume":"68","author":"Bal","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.ijid.2024.107020_bib0003","doi-asserted-by":"crossref","first-page":"ofab250","DOI":"10.1093\/ofid\/ofab250","article-title":"Early stepdown from echinocandin to fluconazole treatment in candidemia: a post hoc analysis of three cohort studies","volume":"8","author":"Moreno-Garc\u00eda","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0004","article-title":"Timing for step-down therapy of candidemia in non-neutropenic patients: an international multi-center study","volume":"13","author":"Raad","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"Suppl.7","key":"10.1016\/j.ijid.2024.107020_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.ijid.2024.107020_bib0006","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","article-title":"Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data","volume":"41","author":"Bailly","year":"2015","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.ijid.2024.107020_bib0007","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/myc.13515","article-title":"Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: a systematic review with qualitative evidence synthesis","volume":"65","author":"Giacobbe","year":"2022","journal-title":"Mycoses"},{"issue":"Suppl 6","key":"10.1016\/j.ijid.2024.107020_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1469-0691.12622","article-title":"Antifungal stewardship in invasive Candida infections","volume":"20","author":"Ruhnke","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.ijid.2024.107020_bib0009","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive candida infections: the ACTIVE trial","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107020_bib0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-11-261","article-title":"Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome","volume":"11","author":"Reboli","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2024.107020_bib0011","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0012","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13613-018-0392-8","article-title":"De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety","volume":"8","author":"Jaffal","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijid.2024.107020_bib0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2022.04.044","article-title":"De-escalation from echinocandins to azole treatment in critically ill patients with candidemia","volume":"121","author":"Lin","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2024.107020_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/myc.12450","article-title":"Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections","volume":"59","author":"Van Der Geest","year":"2016","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/myc.12094","article-title":"An open-label study of anidulafungin for the treatment of candidaemia\/invasive candidiasis in Latin America","volume":"57","author":"Nucci","year":"2014","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.ijid.2024.107020_bib0017","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/CCM.0000000000002867","article-title":"Initial antifungal strategy reduces mortality in critically ill patients with candidemia: a propensity score-adjusted analysis of a multicenter study","volume":"46","author":"Garnacho-Montero","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2024.107020_bib0018","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2147\/CEOR.S141548","article-title":"\u2018De-escalation\u2019 strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany","volume":"9","author":"Van Engen","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.ijid.2024.107020_bib0019","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/13696998.2017.1417312","article-title":"Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China","volume":"21","author":"Chen","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.ijid.2024.107020_bib0020","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ijid.2024.107020_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"7414","key":"10.1016\/j.ijid.2024.107020_bib0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ijid.2024.107020_bib0023","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"issue":"10","key":"10.1016\/j.ijid.2024.107020_bib0024","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/jac\/dkz277","article-title":"MSG-10: a phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis","volume":"74","author":"Spec","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2024.107020_bib0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/jof8010014","article-title":"Antifungal resistance in clinical isolates of candida glabrata in ibero-america","volume":"8","author":"Mart\u00ednez-Herrera","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.ijid.2024.107020_bib0027","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/mmy\/myaa031","article-title":"Update on Candida krusei, a potential multidrug-resistant pathogen","volume":"59","author":"Jamiu","year":"2021","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.ijid.2024.107020_bib0028","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2024.107020_bib0029","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients on micafungin","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.ijid.2024.107020_bib0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","article-title":"Antifungal agents","volume":"187","author":"Chen","year":"2007","journal-title":"Med J Aust"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:01:30Z","timestamp":1715756490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"alternative-id":["S1201971224000912"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107020","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evaluation of antifungal de-escalation in Candida infections: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107020"}}